which provides an amplification factor of about 100 000. A scheme of this activation process is set out in Fig 1 and there is now excellent evidence for the occurrence of each step in the human adipocyte (Burns & Langley 1971 , Tulloch et al. 1972 , Gilbert & Galton 1974 When lipolysis is fully activated it becomes important to have an effective switch-off mechanism. Excessive and continued release of fatty acids into the bloodstream from adipose tissue could cause death due to the toxic effects of high concentrations of fatty acids (resulting in ketoacidosis, denaturation of plasma proteins). Several local tissue mechanisms are available to terminate lipolysis. The enzyme phosphodiesterase actively destroys cyclic-AMP by conversion to 5-AMP. Derivatives of fatty acids, prostaglandins, are released by the adipocyte during lipolysis and these powerfully inhibit adenyl cyclase (Shaw & Ramwell 1968) and prevent further formation of cyclic-AMP. This is a good example of feedback by part of the products of lipolysis inhibiting the first enzyme in the sequence, adenyl cyclase. Finally it is possible that a reset mechanism occurs for the triglyceride lipase by a specific phosphatase which dephosphorylates the activated lipase and so renders it inactive.
It is thus seen how triglyceride lipase in adipose tissue is subject to both positive and negative control in a manner analogous to the control of phosphorylase on the paths of glycogen breakdown. There is also evidence that defects occur on the lipolytic pathway, producing a group of conditions called 'triglyceride storage disease' (Galton et al. 1974) . Three types have so far been tentatively identified. (1) A defect in hormonal stimulation of the receptor-cyclase segment has been observed in adipose tissue of an infant with peripheral deposits of fat. Hormonal stimulation of the cyclase in this infant was estimated in two ways: by measuring the conversion of 14C-ATP to 14C-cyclic-AMP (Kissebah, Galton, Raju, Kemble & Scopes 1970, unpublished) ; by measuring the direct accumulation of cyclic-AMP in tissue. In each case poor activation of the cyclase was observed in the presence of catecholamines.
(2) A second type of defect has been observed in a large family in which adipose tissue of three obese members appears to be stimulated normally by isoprenaline with regard to cyclic-AMP, but this is associated with a reduced output of glycerol from the tissue (Gilbert et al. 1973) . This points to a defect between cyclic-AMP and triglyceride lipase (possibly at the kinase). (3) Finally in the rare condition of primary familial xanthomatosis (Wolman's disease) there is a defect ofa triglyceride lipase in various internal organs (liver, spleen, intestines) associated with excessive storage of triglyceride in foam cells (Kyriakides et al. 1972 ).
It is not known whether this lipase is hormonesensitive but it may be appropriate to classify this condition with the others as a defect in lipolysis.
Conclusion
The molecular details in the hormonal control of lipolysis in the adipocyte have been described. Several types of metabolic defects occur on the lipolytic pathway in different tissues associated with excess triglyceride storage. 
Plasma Triglycerides in Human Diabetes
A mild to moderate elevation of fasting plasma triglyceride level is common in patients with clinical diabetes but exact data on prevalence of hypertriglyceridemia in diabetics as compared to matched nondiabetics are not available (for review see Nikkilii 1973) . Even many of the most recent reports on plasma lipid levels in diabetics (Kudo 1969 , Wilson et al. 1970 , Reimer et al. 1973 , Rodger & Du 1973 do not make adequate comparison with a nondiabetic population which has a similar age and body weight distribution. When the reference values are taken from normal young people the absolute prevalence rates of hyperlipoproteinemia are correct but the relative frequency of elevated serum lipid levels attributed to diabetes is overestimated since the material usually includes an excess of obese middle-aged or older individuals who basically show a substantial frequency of lipid abnormali-ties. Anyway, at all relative body weight levels diabetics have a higher mean triglyceride concentration than nondiabetics (Braunsteiner et al. 1966) .
Hypertriglyceridwmia in Different Forms ofDiabetes
The occurrence of elevated blood lipid levels in diabetes is related to the nature of the disease and to the adequacy of control but there are many exceptions to these rules. Patients with ketoacidosis show regularly a moderate hypertriglyceridaemia (increase of very low density lipoproteins (VLDL)) but in some cases this does not occur while other patients develop a gross hyperlipaemia during a modest ketosis (Bagdade et al. 1967 ). Among the diabetic patients with ketoacidosis admitted to the University Hospital of Helsinki the plasma triglyceride level was more or less increased in 91 %. Upon treatment the triglyceride decreases, and many of the insulin-treated juvenile-type diabetics show normal plasma lipid values even when they have an inadequate control of hyperglyctmia. Of the insulin-treated diabetic patients regularly visiting the diabetes unit of Helsinki University Hospital, only 20% exceeded the 90th percentile limit of plasma triglyceride of a normal population of similar age. In other words, 80% of these patients had normal plasma triglyceride and the frequency of hypertriglyceridemia was twice as high as in the normal population. In the absence of ketoacidosis there was no correlation between fasting blood glucose and plasma triglyceride levels. However, all the patients who had elevated plasma triglyceride had fasting blood glucose above 150 mg/100 ml. Within one individual there may be a correlation between fasting triglyceride and blood glucose levels but the regression may be highly variable and the triglyceride may start to rise only at higher blood glucose concentrations, as exemplified by the three illustrative cases presented in It is thus evident that patients with insulindependent diabetes are not very prone to develop hypertriglyceridcemia in the absence of ketoacidosis. Many patients in whom the disease is rather poorly controlled have both triglyceride and cholesterol levels within a range which is normal for their age and a good control almost guarantees normal serum lipid levels. However, there is a definite trend for increase of plasma triglyceride with failure of diabetic treatment. Prevalence of hypertriglyceridwmia increases on development of microvascular complications or obesity.
In adult-onset type diabetes the fasting triglyceride values are highly variable but the prevalence of hypertriglyceridaemia is markedly increased over that in an age-matched control population. The prevalence rates may be much influenced by case selection if they are not based on population studies. Thus, any clinical material of adult-onset type diabetics contains more severe cases and probably also many patients with hyperlipoproteinemia, since these are more easily admitted to observation and treatment in a special unit than are cases with mild and uncomplicated diabetes. In a material collected from our diabetes unit the frequency of elevated plasma triglyceride levels in all noninsulin-treated diabetics was 35% when the 90th percentile of age-matched basic population was used as the upper normal limit. This value may be biased upwards, however, since hyperlipidemic diabetics may have been concentrated into the material. Also in this group of diabetics the triglyceride and blood glucose levels are poorly correlated, except that intraindividual values usually undergo more or less parallel changes on treatment or during failure of treatment.
Obesity is associated with hypertriglycerideemia in adult-onset type diabetics more closely than with the degree of hyperglycaemia. Nonobese diabetic patients have a plasma triglyceride distribution pattern which is closer to normal than that of obese nondiabetics.
The degree of hyperti-iglycerideemia in noninsulin-dependent diabetes is usually moderate, most values being less than 300 mg/100 ml. The lipoprotein pattern is typically of Type IV without any increase of LDL and serum cholesterol levels. When both lipids are increased (Type IIB) it is probable that the patient has a familial multiple-type (combined) hyperlipidemia or some other disease which elevates serum cholesterol.
A minor group of diabetics show an excessive increase of plasma triglycerides which cannot be lowered by adequate control of the hyperglycwemia with diet and drugs. This syndrome has been described by Thannhauser (1947) and by Proc. roy. Soc. Med. Volume 67July 1974 Adlersberg & Wang (1955) and it is probably more or less identical with the 'diabetic lipemia' of Bagdade et al. (1967) which occurs in connection with insulin deficiency and moderate ketosis. One variant of this disease is not very infrequent in older women with mild to moderate diabetes and without any cutaneous xanthomatosis which is characteristic of the Thannhauser-Aldersberg syndrome. Just to avoid any presumption on the primary biochemical error we have recently called this disorder as 'diabetichyperlipaemic syndrome' (Nikkila & Kekki 1973) .
Mechanism ofHypertriglyceridamia in Diabetes
Basal (postabsorptive) plasma triglyceride level is regulated by the rate of production of circulating triglycerides and by the efficiency of their removal. Ultimately, the latter factor is crucial since a highly efficient metabolic clearance attenuates the effect of production rate on plasma triglyceride concentration whereas in a subject with low removal capacity hypertriglyceridTmia develops readily even on a small increase of triglyceride influx into circulation. Furthermore, hypertriglyceridemia itself reduces the fractional removal of any additional fat load irrespective of whether there is a primary defect in clearance or not.
The mechanisms of different forms of diabetesassociated hypertriglycerideemia are not yet completely understood, but it is evident that they vary from a pure removal failure to a state of marked overproduction of plasma triglycerides. Usually both factors contribute simultaneously.
In severe insulin deficiency as manifested by an increase of plasma FFA and ketone bodies the influx of triglycerides into circulation is regularly increased and the fractional removal of endogenous triglycerides is often decreased (Nikkila & Kekki 1973 ). On treatment with insulin the triglyceride production rate falls to the normal range whereas the fractional elimination rate may increase or remain unchanged. In linear regression analysis of our material a significant correlation was obtained between triglyceride concentration and turnover rate which suggests that the triglyceride removal is probably decreased in severe diabetes (see above). An insufficient removal is likely to be present in those exceptional cases which develop a gross hyperlipemia in association with moderate ketosis ('diabetic hyperlipsemia' of Bagdade et al. 1967 ). However, proof for the primary nature of this defect can be obtained only by studying the patients after their plasma triglyceride level has been lowered.
The most plausible explanation for the overproduction of plasma triglycerides in insulindeficient diabetes is the increased influx of FFA into the liver and esterification into secretory triglycerides. Deficient removal is probably related to suppression ofadipose tissue and muscle lipoprotein lipase by high intracellular FFA or cyclic AMP.
In diabetics with low insulin secretion (ketosis not present, plasma FFA often normal) there is usually no abnormality of plasma triglyceride metabolism but when hypertriglyceridemia occurs it seems to be mainly due to an enhanced hepatic production of circulating triglycerides (Nikkilii & Kekki 1973 ). We have not been able to demonstrate any major defect in triglyceride clearance in this form of diabetes but Lewis et al. (1972) believe that such is present and might account for the hypertriglyceridcemia. The difficulty lies in the interpretation of the results of fat tolerance (Intralipid) test: whether a decrease of fractional removal indicates a primary impairment of clearance of fat from the blood or merely reflects the saturability of the removal system in the presence of an enlarged endogenous triglyceride pool.
It is not entirely clear what factors are responsible for the increased production of plasma triglycerides in some diabetics with subnormal insulin secretion. One possibility is that high blood glucose concentration in the presence of even low insulin levels stimulates the hepatic fatty acid and glyceride synthesis (Ontko 1972) . In support of this view is the finding that fasting blood glucose level shows a weak positive correlation with plasma triglyceride influx rate (Sailer et al. 1967 , Nikkila & Kekki 1973 ). An additional factor could be the occasional increase of plasma FFA. Even though the basal FFA levels are often within the normal range in a lowinsulin diabetic they may show an exaggerated response to physiological stimuli like exercise (Carlstrom 1967) .
In diabetics with normal or increased plasma insulin values ('insulin-resistant type') hypertriglyceridcmia may be caused either by overproduction or by defective clearance of plasma triglycerides (Nikkila & Kekki 1973 ). An abnormally high triglyceride influx rate into the blood can usually be demonstrated in markedly overweight younger subjects with hypertriglyceridcmia. The enhanced production of plasma triglycerides in these cases could be accounted for by the presence of hyperglycxmia, hyperinsulinemia and increased level of plasma FFA all of which factors stimulate hepatic fatty acid synthesis, triglyceride formation and lipoprotein secretion (Tulloch et al. 1972 , Topping & Mayes 1972 . The patients with impaired removal of triglycerides from the circulation are usually older, moderately obese and their diabetes is mild to moderate and easily controlled. The plasma insulin is not increased. They often develop a gross hyperlipemia in response to increase of dietary carbohydrate or even without any dietary induction. The precise nature of the defect and its tissue localization have not yet been defined. It is also unknown to what extent the disorder is genetically determined.
Plasma Triglyceride Turnover in Relation to Insulin Secretion In Fig 2 plasma triglyceride turnover rate and concentration are illustrated separately for diabetics with and without insulin deficiency. Both parameters of triglyceride metabolism are evidently independent of the insulin secretory status. We have also been unable to demonstrate any relationship between the fractional clearance rate of exogenous or endogenous plasma triglycerides on the one hand and the magnitude of plasma insulin response to glucose or arginine on the other. These observations do not indicate that insulin is without effect on the synthesis or removal of plasma triglycerides but they suggest that the level and influx and efflux rates of plasma triglycerides in diabetes are determined by many factors besides insulin. Future work should concentrate on the relationship between triglyceride metabolism and growth hormone, glucagon and catecholamines, all of which are elevated in plasma in diabetes.
Conclusion
Hypertriglyceridwmia in diabetes mellitus may arise through different mechanisms which are not yet completely understood. Individual differences are as large as they appear to be in a nondiabetic population and the lipoprotein genotype certainly plays an important role also in many cases with 'diabetic' hyperlipidcamia. When plasma triglyceride level is elevated in a diabetic it is usually mainly due to an accelerated influx rate of triglycerides from the liver into the circulation. However, in some cases -notably those developing a gross hyperlipwmia -an impaired removal of triglycerides is a contributory factor or the only cause of hypertriglyceridwmia.
